体外循环后血管麻痹综合征的治疗  

Therapy of vasoplegic syndrome after cardiopulmonary bypass

作　　者：李明[1] 张总刚[2] 杜宇奎[2] 阿依别克[2] 艾力[2] 

机构地区：[1]暨南大学附属珠海医院心胸外科,珠海519000 [2]新疆维吾尔自治区人民医院心外科,新疆830001

出　　处：《中国体外循环杂志》2013年第2期101-102,115,共3页Chinese Journal of Extracorporeal Circulation

摘　　要：目的总结体外循环心脏术后血管麻痹综合征(VS)的诊断及治疗。方法 2006年8月至2012年10月我院共完成体外循环心脏手术2 021例,期间发生11例体外循环术后VS,均在术后6 h内得到确诊。结果 11例VS患者心脏术后早期均表现严重低血压伴血流动力学高排低阻现象。所有患者经大剂量缩血管药物治疗,均顺利出院。结论 VS是心脏外科术后较少见的并发症,救治成功的关键在于早期正确诊断,尽早使用合适的缩血管药物。Objective To analyze the diagnosis and treatment of vasopiegic syndrome （VS） after heart surgery undergoing cardiopulmonary bypass （CPB）. Methods We retrospectively analyzed 11 patients diagnosed with VS among 2021 cases performed open heart surgery with CPB from August 2006 to October 2012. For these 11 patients, ~S was confirmed in 6 hours after patients were transferred back to intensive care unit. This study summarized clinic syndrome and therapy strategy of these 11 patients with VS. Re- suits VS patients were identified with high heart output and low systemic resistance during the early period after open heart procedure with CPB. VS patients require intravenously continuous injection of large doses of vasoconstrictor to maintain hemodynamic stabiliza- tion. All of these patients were discharged successfully from hospital without any other complications. Conclusion VS is a rare com- plication of patients underwent cardiac procedure with CPB. The key strategy of the therapy is proper vasoconstrictor infusion after early accurate diaanosis in ICU.

关 键 词：体外循环 血管麻痹综合征 缩血管药物 

分 类 号：R654.1[医药卫生—外科学]